| The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1. | |
| | |
MedLine Citation:
|
PMID: 15001579 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Although plasminogen activator inhibitor-1 (PAI-1) is known to stimulate cell migration, little is known about underlying mechanisms. We show that both active and inactive (e.g. cleaved) PAI-1 can activate the Jak/Stat signaling system and stimulate cell migration in chemotaxis, haptotaxis, chemokinesis, and wound healing assays. Moreover, antibodies to the LDL receptor-related protein (LRP) and an LRP antagonist (RAP) blocked these motogenic effects of PAI-1, while a PAI-1 mutant that did not bind to LRP failed to activate the Jak/Stat signaling pathway or to stimulate cell migration. PAI-1 had no chemotactic effect on LRP-deficient cells. These results indicate that LRP is a signaling molecule, that it mediates the migration-promoting activity of PAI-1, and that this activity does not require intact, biologically active PAI-1. Activation of this LRP-dependent signaling pathway by PAI-1 may begin to explain how the inhibitor stimulates cell migration in a variety of normal and pathological processes. |
| | |
Authors:
|
Bernard Degryse; Jaap G Neels; Ralf-Peter Czekay; Kathleen Aertgeerts; Yu-Ichi Kamikubo; David J Loskutoff |
Related Documents
:
|
21384399 - Nrf2/ho-1 pathway activation by manganese is associated with reactive oxygen species an... 21419339 - Inhibition of protein phosphatase 2a activity by pi3kγ regulates β-adrenergic recepto... 21118399 - Astrocyte erk phosphorylation precedes k(+) -induced swelling but follows hypotonicity-... 21508279 - Targeting inflammatory kinase as an adjuvant treatment for osteosarcomas. 1950579 - Effects of four chemicals on n-acetyltransferase activities in human u937 cell line. 3930479 - Endothelial cells produce a latent inhibitor of plasminogen activators that can be acti... 2000399 - Long-chain (sphingoid) bases inhibit multistage carcinogenesis in mouse c3h/10t1/2 cell... 21536449 - Design and evaluation of 3-aminopyrazolopyridinone kinase inhibitors inspired by the na... 9520369 - Depudecin induces morphological reversion of transformed fibroblasts via the inhibition... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. Date: 2004-03-04 |
Journal Detail:
|
Title: The Journal of biological chemistry Volume: 279 ISSN: 0021-9258 ISO Abbreviation: J. Biol. Chem. Publication Date: 2004 May |
Date Detail:
|
Created Date: 2004-05-17 Completed Date: 2004-06-30 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 2985121R Medline TA: J Biol Chem Country: United States |
Other Details:
|
Languages: eng Pagination: 22595-604 Citation Subset: IM |
Affiliation:
|
Department of Cell Biology, The Scripps Research Institute, VB-3, La Jolla, California 92037, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Actins
/
metabolism Active Transport, Cell Nucleus Blotting, Western Cell Line Cell Line, Tumor Cell Membrane / metabolism Cell Movement Cells, Cultured Chemotaxis Cytoskeleton / metabolism Dose-Response Relationship, Drug Humans Kinetics LDL-Receptor Related Protein 1 / physiology* Microscopy, Fluorescence Mutation Phosphotyrosine / chemistry Plasminogen Activator Inhibitor 1 / metabolism* Precipitin Tests Protein Binding Reverse Transcriptase Polymerase Chain Reaction Signal Transduction Surface Plasmon Resonance Time Factors Tyrosine / chemistry Wound Healing |
| Grant Support | |
ID/Acronym/Agency:
|
HL31950/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Actins; 0/LDL-Receptor Related Protein 1; 0/Plasminogen Activator Inhibitor 1; 21820-51-9/Phosphotyrosine; 55520-40-6/Tyrosine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes.
Next Document: Hsp90/p50cdc37 is required for mixed-lineage kinase (MLK) 3 signaling.